loadpatents
name:-0.041604042053223
name:-0.031831979751587
name:-0.0086770057678223
Huang; Tammy T. Patent Filings

Huang; Tammy T.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Huang; Tammy T..The latest application filed is for "anti-pcsk9 antibodies".

Company Profile
7.31.38
  • Huang; Tammy T. - Cross River NY
  • HUANG; Tammy T. - Golden Bridge NY
  • HUANG; Tammy T. - Goldens Bridge NY
  • Huang; Tammy T - Goldens Bridge NY
  • Huang; Tammy T. - Fremont CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
High affinity antibodies to human IL-6 receptor
Grant 11,370,843 - Stevens , et al. June 28, 2
2022-06-28
Anti-pcsk9 Antibodies
App 20210253735 - SLEEMAN; Mark W. ;   et al.
2021-08-19
High Affinity Human Antibodies To Human Il-4 Receptor
App 20210163611 - MARTIN; Joel H. ;   et al.
2021-06-03
Anti-PCSK9 antibodies
Grant 10,941,210 - Sleeman , et al. March 9, 2
2021-03-09
High Affinity Antibodies To Human Il-6 Receptor
App 20210009698 - Stevens; Sean ;   et al.
2021-01-14
Vl Antigen Binding Proteins Exhibiting Distinct Binding Characteristics
App 20200377618 - Babb; Robert ;   et al.
2020-12-03
V.sub.L antigen binding proteins exhibiting distinct binding characteristics
Grant 10,787,522 - Babb , et al. September 29, 2
2020-09-29
Nucleic acids encoding high affinity antibodies to human IL-6 receptor
Grant 10,584,173 - Stevens , et al.
2020-03-10
High Affinity Antibodies To Human Il-6 Receptor
App 20190256606 - Stevens; Sean ;   et al.
2019-08-22
Anti-pcsk9 Antibodies
App 20190135941 - Sleeman; Mark W. ;   et al.
2019-05-09
Vl Antigen Binding Proteins Exhibiting Distinct Binding Characteristics
App 20180273641 - Babb; Robert ;   et al.
2018-09-27
Anti-PCSK9 antibodies
Grant 10,023,654 - Sleeman , et al. July 17, 2
2018-07-17
High Affinity Human Antibodies To Human Il-4 Receptor
App 20180179288 - MARTIN; Joel H. ;   et al.
2018-06-28
High affinity antibodies to human IL-6 receptor
Grant 9,884,916 - Stevens , et al. February 6, 2
2018-02-06
Methods for Treating Hypercholesterolemia and Reducing LDL-C Using Antibodies to PCSK9
App 20170296657 - Sleeman; Mark W. ;   et al.
2017-10-19
Methods for treating hypercholesterolemia and reducing LDL-C using antibodies to PCSK9
Grant 9,724,411 - Sleeman , et al. August 8, 2
2017-08-08
ANTI-PCSK9 ANTIBODIES WITH pH-DEPENDENT BINDING CHARACTERISTICS
App 20170096496 - SLEEMAN; Mark W. ;   et al.
2017-04-06
Therapeutic uses of anti-PCSK9 antibodies
Grant 9,550,837 - Sleeman , et al. January 24, 2
2017-01-24
High Affinity Antibodies To Human Il-6 Receptor
App 20160229916 - STEVENS; Sean ;   et al.
2016-08-11
Method of treating rheumatoid arthritis with an anti-IL-6R antibody
Grant 9,308,256 - Radin , et al. April 12, 2
2016-04-12
ANTI-PCSK9 ANTIBODIES WITH pH-DEPENDENT BINDING CHARACTERISTICS
App 20150284474 - SLEEMAN; Mark W. ;   et al.
2015-10-08
Vl Antigen Binding Proteins Exhibiting Distinct Binding Characteristics
App 20150266976 - Babb; Robert ;   et al.
2015-09-24
High Affinity Human Antibodies to Human IL-4 Receptor
App 20140271681 - Martin; Joel H. ;   et al.
2014-09-18
Method of Treating Rheumatoid Arthritis With An Anti-IL-6R Antibody
App 20140255390 - Radin; Allen ;   et al.
2014-09-11
High Affinity Antibodies To Human Il-6 Receptor
App 20140255995 - Stevens; Sean ;   et al.
2014-09-11
High affinity human antibodies to human IL-4 receptor
Grant 8,735,095 - Martin , et al. May 27, 2
2014-05-27
Methods for Treating Hypercholesterolemia and Reducing LDL-C Using Antibodies to PCSK9
App 20140099312 - Sleeman; Mark W. ;   et al.
2014-04-10
Method of treating rheumatoid arthritis with an anti-IL-6R antibody
Grant 8,568,721 - Radin , et al. October 29, 2
2013-10-29
High affinity human antibodies to PCSK9
Grant 8,501,184 - Sleeman , et al. August 6, 2
2013-08-06
High Affinity Antibodies To Human Il-6 Receptor
App 20130157313 - Stevens; Sean ;   et al.
2013-06-20
ANTI-PCSK9 ANTIBODIES WITH pH-DEPENDENT BINDING CHARACTERISTICS
App 20130085266 - SLEEMAN; Mark W. ;   et al.
2013-04-04
High Affinity Human Antibodies To Human Il-4 Receptor
App 20130078675 - MARTIN; Joel H. ;   et al.
2013-03-28
Methods For Treating Hypercholesterolemia Using Antibodies To Pcsk9
App 20130064834 - SLEEMAN; Mark W. ;   et al.
2013-03-14
Methods for treating hypercholesterolemia using antibodies to PCSK9
Grant 8,357,371 - Sleeman , et al. January 22, 2
2013-01-22
High affinity human antibodies to human IL-4 receptor
Grant 8,337,839 - Martin , et al. December 25, 2
2012-12-25
High affinity human antibodies to human IL-4 receptor
Grant 8,338,135 - Stevens , et al. December 25, 2
2012-12-25
Method of Treating Rheumatoid Arthritis with an Anti-IL-6R Antibody
App 20120258098 - Radin; Allen ;   et al.
2012-10-11
Method of treating rheumatoid arthritis with an anti-IL-6R antibody
Grant 8,192,741 - Radin , et al. June 5, 2
2012-06-05
High Affinity Human Antibodies To Human Il-4 Receptor
App 20120135010 - Stevens; Sean ;   et al.
2012-05-31
High affinity antibodies to human IL-6 receptor
Grant 8,183,014 - Stevens , et al. May 22, 2
2012-05-22
High Affinity Human Antibodies To Human Il-4 Receptor
App 20120052072 - Martin; Joel H. ;   et al.
2012-03-01
Method Of Treating Rheumatoid Arthritis With An Anti-il-6r Antibody
App 20120045440 - Radin; Allen ;   et al.
2012-02-23
High affinity human antibodies to human IL-4 receptor
Grant 8,092,802 - Stevens , et al. January 10, 2
2012-01-10
High Affinity Antibodies To Human Il-6 Receptor
App 20120003697 - STEVENS; Sean ;   et al.
2012-01-05
Method of treating rheumatoid arthritis with an IL-6R antibody
Grant 8,080,248 - Radin , et al. December 20, 2
2011-12-20
High affinity human antibodies to human IL-4 receptor
Grant 8,075,887 - Martin , et al. December 13, 2
2011-12-13
High affinity human antibodies to PCSK9
Grant 8,062,640 - Sleeman , et al. November 22, 2
2011-11-22
Human antibodies to human IL-6 receptor
Grant 8,043,617 - Stevens , et al. October 25, 2
2011-10-25
Methods for Treating Hypercholesterolemia Using Antibodies to PCSK9
App 20110256148 - SLEEMAN; MARK W. ;   et al.
2011-10-20
High Affinity Human Antibodies To Pcsk9
App 20110065902 - Sleeman; Mark W. ;   et al.
2011-03-17
Human antibodies to human IL-6 receptor
App 20100316627 - Stevens; Sean ;   et al.
2010-12-16
Method of Treating Rheumatoid Arthritis with an IL-6R Antibody
App 20100316636 - Radin; Allen ;   et al.
2010-12-16
High Affinity Human Antibodies To Human Il-4 Receptor
App 20100291107 - Stevens; Sean ;   et al.
2010-11-18
High affinity human antibodies to human IL-4 receptor
Grant 7,794,717 - Stevens , et al. September 14, 2
2010-09-14
High Affinity Human Antibodies to PCSK9
App 20100166768 - Sleeman; Mark W. ;   et al.
2010-07-01
High Affinity Human Antibodies to Human IL-4 Receptor
App 20100047254 - Martin; Joel H. ;   et al.
2010-02-25
High Affinity Human Antibodies to Human IL-4 Receptor
App 20100021476 - Stevens; Sean ;   et al.
2010-01-28
High affinity human antibodies to human IL-4 receptor
Grant 7,608,693 - Martin , et al. October 27, 2
2009-10-27
High affinity human antibodies to human IL-4 receptor
Grant 7,605,237 - Stevens , et al. October 20, 2
2009-10-20
High affinity antibodies to human IL-6 receptor
Grant 7,582,298 - Stevens , et al. September 1, 2
2009-09-01
High Affinity Human Antibodies to Human IL-4 Receptor
App 20090074793 - Martin; Joel H. ;   et al.
2009-03-19
High affinity human antibodies to human IL-4 receptor
App 20080160035 - Stevens; Sean ;   et al.
2008-07-03
High affinity antibodies to human IL-6 receptor
App 20070280945 - Stevens; Sean ;   et al.
2007-12-06
Integrated design system and method for reducing and avoiding crosstalk
Grant 6,907,586 - Al-Dabagh , et al. June 14, 2
2005-06-14
Integrated design system and method for reducing and avoiding crosstalk
Grant 6,594,805 - Tetelbaum , et al. July 15, 2
2003-07-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed